This was the first of six webinars held virtually during the months of February and March 2021 to provide guidance on pharmacogenomics and understand the health equity implications of adoption.
The webinars were sponsored by AMA and ASHP (American Society of Health-System Pharmacists).
Pharmacogenomics landscape
Leading experts introduced pharmacogenomics and the value it can bring to patient care.
This webinar:
- Discussed the benefits and limitations of pharmacogenomics
- Identified the institution perspective on the value of pharmacogenomic testing
- Discussed the economic environment around pharmacogenomics
- Identified an international perspective on the use of pharmacogenomics for prescribing decisions
- Described a patient experience navigating pharmacogenomics
- Recognized the role of health equity in pharmacogenomics
Panel discussion
Moderators
Mira Irons, MD, former AMA chief health and science officer
Julie A. Johnson, PharmD, dean of the University of Florida College of Pharmacy and distinguished professor of pharmacy and medicine
Agenda
- Welcome and introduction—Mira Irons, MD
- What can pharmacogenomic testing do?—Mary V. Relling, PharmD (St. Jude Children’s Research Hospital)
- Institution perspective—Peter J. Hulick, MD, MMSc, FACMG (NorthShore University Healthsystem)
- Economics: Payment & policy landscape—Sara Rogers, PharmD, BCPS (American Society of Pharmacovigilance)
- 100,000 genomes project and pharmacogenomics: UK perspective—Sir Munir Pirmohamed, MB ChB (Hons), PhD, FRCP, FRCP(E), FBPhS, FFPM, FMedSci (University of Liverpool)
- Patient voice—Trish Brown, MS, CGC (Illumina)
- Health equity—Esteban G. Burchard, MD, MPH (University of California, San Francisco)
- Q&A
- Future directions & wrap-up
Speakers' bios
Download the PDF for full speaker bios.
CME/CPE opportunities
ASHP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education and by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This jointly sponsored online activity offers two hours of CPE credit to pharmacists or CME credit to physician attendees. Pharmacists and physicians are eligible to receive a total of 12.00 hours of continuing education credit by attending all six events.
Participants must participate in the entire activity, complete the evaluation and all required components to claim continuing education credit online at ASHP eLearning Portal. Follow the prompts to claim credit and view your statement of credit within 60 days after completing the activity.
Additional summits
Visit the Pharmacogenomics Virtual Summit Series page for information on other summits in the series.
